Abstract:Background: Airborne nanoparticles can be inhaled and deposit in human alveoli, where pulmonary surfactant (PS) molecules lining at the alveolar air-water interface act as the first barrier against inhaled nanoparticles entering the body. Although considerable efforts have been devoted to elucidate the mechanisms underlying nanoparticle-PS interactions, our understanding on this important issue is limited due to the high complexity of the atmosphere, in which nanoparticles are believed to experience transformations that remarkably change the nanoparticles' surface properties and states. By contrast with bare nanoparticles that have been extensively studied, relatively little is known about the interactions between PS and inhaled nanoparticles which already adsorb contaminants. In this combined experimental and computational effort, we investigate the joint interactions between PS and graphene-family materials (GFMs) with coexisting benzo[a]pyrene (BaP). Results: Depending on the BaP concentration, molecular agglomeration, and graphene oxidation, different nanocomposite structures are formed via BaPs adsorption on GFMs. Upon deposition of GFMs carrying BaPs at the pulmonary surfactant (PS) layer, competition and cooperation of interactions between different components determines the interfacial processes including BaP solubilization, GFM translocation and PS perturbation. Importantly, BaPs adsorbed on GFMs are solubilized to increase BaP's bioavailability. By contrast with graphene adhering on the PS layer to release part of adsorbed BaPs, more BaPs are released from graphene oxide, which induces a hydrophilic pore in the PS layer and shows adverse effect on the PS biophysical function. Translocation of graphene across the PS layer is facilitated by BaP adsorption through segregating it from contact with PS, while translocation of graphene oxide is suppressed by BaP adsorption due to the increase of surface hydrophobicity. Graphene extracts PS molecules from the layer, and the resultant PS depletion declines with graphene oxidation and BaP adsorption. Conclusion: GFMs showed high adsorption capacity towards BaPs to form nanocomposites. Upon deposition of GFMs carrying BaPs at the alveolar air-water interface covered by a thin PS layer, the interactions of GFM-PS, GFM-BaP and BaP-PS determined the interfacial processes of BaP solubilization, GFM translocation and PS perturbation.

Joint Interactions of Graphene and Benzo[a]pyrene With Pulmonary Surfactant

Competitive and/or cooperative interactions of graphene-family materials and benzo[a]pyrene with pulmonary surfactant: a computational and experimental study

Extracting pulmonary surfactants to form inverse micelles on suspended graphene nanosheets

Heterogeneous aggregation of carbon and silicon nanoparticles with benzo[ a ]pyrene modulates their impacts on the pulmonary surfactant film

Study Interactions Between Inhaled Nanoparticles and Pulmonary Surfactant Using Molecular Dynamics Simulations

Dual role of pulmonary surfactant corona in modulating carbon nanotube toxicity and benzo[a]pyrene bioaccessibility

The Aggregation of Carbon Nanotubes Deteriorates Their Adverse Effects on Pulmonary Surfactant Monolayer

Computational Investigations of the Interaction Between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

Molecular Modeling of Interaction Between Lipid Monolayer and Graphene Nanosheets: Implications for Pulmonary Nanotoxicity and Pulmonary Drug Delivery

Nanoparticle Translocation Across the Lung Surfactant Film Regulated by Grafting Polymers.

A Simulation Study on the Interaction Between Pollutant Nanoparticles and the Pulmonary Surfactant Monolayer

The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants

Transport Of Nanoparticles Across Pulmonary Surfactant Monolayer: A Molecular Dynamics Study

A Review on Investigating the Interactions between Nanoparticles and the Pulmonary Surfactant Monolayer with Coarse-Grained Molecular Dynamics Method

Pulmonary surfactant inhibition of nanoparticle uptake by alveolar epithelial cells

Lipid extraction mediates aggregation of carbon nanospheres in pulmonary surfactant monolayers.

The Role of Basic Residues in the Adsorption of Blood Proteins Onto the Graphene Surface

Size‐Dependent Pulmonary Impact of Thin Graphene Oxide Sheets in Mice: Toward Safe‐by‐Design

Real-time Monitoring of the Effect of Carbon Nanoparticles on the Surface Behavior of DPPC/DPPG Langmuir Monolayer

Biophysical influence of airborne carbon nanomaterials on natural pulmonary surfactant

Physicochemical Properties of Nanoparticles Affect Translocation Across Pulmonary Surfactant Monolayer